CE Mark Granted for Rapid Bacterial vs Viral Infection Test
The high-throughput host-response assay provides results in approximately 20 minutes to help guide treatment decisions and antimicrobial stewardship.
Category: Infectious Diseases
Infectious Diseases
Latest
Infectious Diseases
Latest
Antibody Test for Mpox Validated During Active Outbreak in Rwanda
Researchers have validated an IgG ELISA assay for mpox during an active outbreak in Rwanda, enabling distinction between infection- and vaccine-derived immunity, according to findings published in The Lancet Infectious Diseases.
Infectious Diseases
Latest
New US Lab Panel Targets Hard-to-Diagnose Liver Fluke Infections
The 3-test panel detects antibodies for parasitic infections that affect up to 45 million people globally and are linked to bile duct cancer.
Emerging & Zoonotic Diseases
Latest
Molecular Platform Shows Promise for Detecting Asymptomatic Malaria Cases
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Flu & Respiratory Infections
Latest
How Labs Can Stay Ahead of Respiratory Season
From assay validation to staffing and supply chain planning, labs can take steps to manage testing surges during flu and RSV season.
Gastrointestinal Infections
Latest
FDA Clears Cepheid’s Multiplex GI Pathogen Panel
The PCR test detects 11 bacterial, viral, and parasitic pathogens from a stool sample in approximately 74 minutes.
Sexually Transmitted Diseases
Latest
Nexus Medical Labs Partners with Lybe Scientific for Nucleic Acid Extraction Technology
Nexus Medical Labs will implement Lybe Scientific’s NAxtra nucleic acid extraction kit in a 60,000-plus test unit deal to enhance high-throughput STI testing, citing improved detection limits and workflow efficiency.